Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare disease response of Albumin-bound paclitaxel
(ABI-007) plus Carboplatin versus Taxol and Carboplatin as first-line therapy in patients
with advanced non-small cell lung cancer (NSCLC).